---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-031201"
form_type: "8-K"
ticker: null
cik: "0001792581"
company_name: "Kiromic Biopharma, Inc."
filed_at: "2023-03-10T23:59:59+00:00"
generated_at: "2026-06-18T05:42:17.762605+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Kiromic BioPharma effects 1-for-30 reverse stock split to regain Nasdaq compliance

## Summary
- Reverse split at 1-for-30 effective March 10, 2023 at 4:01 pm ET; trading on split-adjusted basis March 13.
- Post-split shares outstanding approximately 966,758; fractional shares rounded up to whole share.
- Trading symbol KRBP unchanged; new CUSIP number 497634204.
- Split approved by stockholders on March 7, 2023; board set ratio at 1-for-30.
- Primary purpose: meet Nasdaq minimum bid price requirement for continued listing.

## SEC filing metadata
- accession: 0001104659-23-031201
- form_type: 8-K
- cik: 0001792581
- company_name: Kiromic Biopharma, Inc.
- filed_at: 2023-03-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1792581/000110465923031201/0001104659-23-031201-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1792581/000110465923031201/tm239172d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-031201
- JSON: https://secwatch.observer/filing/0001104659-23-031201.json
- Plain text: https://secwatch.observer/filing/0001104659-23-031201.txt

## Key facts
- Governance Changes
  Kiromic Biopharma, Inc.: Amended certificate of incorporation to effect a 1-for-30 reverse stock split, effective 4:01 p.m. ET on March 10, 2023 (effective 2023-03-10).
  - Change: charter amendment
  - Effective: 2023-03-10
  source text: On March 10, 2023, the Company filed with the Secretary of State of the State of Delaware a certificate of amendment to its certificate of incorporation (the “Certificate of Amendment”) to effect the Reverse Stock Split.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1792581/000110465923031201/0001104659-23-031201-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.